With your support, we have been able to fund outstanding research, leading toward cures and improved quality of life for children with cancer. Browse through our nearly 1,000 funded projects below.
Use the search tool to refine your results. You can also click on a heading to sort by project title, institution name, or year the grant was awarded. Click on the project title to read more information.
ALSF Funded Research Projects
|Project Title||Institution / Principal Investigator(s)||Grant Type||Year||State|
|Increasing the Availability and Quality of Early Phase Clinical Trials Through the Addition of a Specialized Pediatric Advanced Nurse Practitioner||Children's Memorial Hospital / Stewart Goldman||Phase I/II Infrastructure Grants||2008||Illinois|
|Children's Hospital of Pittsburgh Phase 1-2 Infrastructure Support Grant||University of Pittsburgh / A. Kim Ritchey, MD||Phase I/II Infrastructure Grants||2008||Pennsylvania|
|A New York Based Pediatric Oncology Developmental Therapeutics Program||Columbia University / Julia Glade Bender, MD||Phase I/II Infrastructure Grants||2008||New York|
|Advanced Therapeutics for Pediatric Cancer||Seattle Children's Hospital and Regional Medical Center / Julie Park, MD||Phase I/II Infrastructure Grants||2008||Washington|
|Parallel sequencing to identify the causes of childhood cancer||Baylor College of Medicine / Sharon Plon||Innovation Grants||2008||Texas|
|Molecular Regulation of CNS Involvement in Pediatric ALL||New York University School of Medicine / Iannis Aifantis, PhD||Innovation Grants||2008||New York|
|PI-3 kinase as a novel and attractive target in pediatric cancer and neuroblastoma||Emory University / Donald Durden||Innovation Grants||2008||Georgia|
|Preclinical Studies of Gli1 Inhibition in Ewing Family Tumors||Children's Hospital Los Angeles / William May||Innovation Grants||2008||California|
|HMG-I/Y in Pediatric Leukemia and Lymphoma||The Johns Hopkins University School of Medicine / Linda Smith Resar, MD||Innovation Grants||2008||Maryland|
|The role of OCT4 in self-renewal signaling and drug-resistance of childhood acute lymphoblastic leukemia||Children's Hospital Los Angeles / Markus Muschen||Innovation Grants||2008||California|